The Radiopharmaceutical Infrastructure Playbook: Why Telix's FDA Approval for Pixclara Redefines Neuro-Oncology Diagnostics and Theranostics
Dr. Dereck Mush, MD, MBA
Telix Pharmaceuticals
A commercial-stage biopharmaceutical company focused on diagnostic and therapeutic radiopharmaceuticals.
What they do
Telix develops precision oncology products that pair molecular imaging with targeted radiation therapies, including its glioma imaging and therapeutic programs.
The record
- Vertical
- Oncology
- Sub-segment
- Radiopharmaceuticals and theranostics
- Product type
- Diagnostics
- Stage
- Public
- Headquarters
- Melbourne, Australia
- Region
- Oceania
- Founded
- 2015
- Total funding
- Undisclosed
Also in Oncology
Related on The Signal
Dr. Dereck Mush, MD, MBA
The ALK2 Opening: What Atebrioz Means for Rare Bone Disease
Dr. Dereck Mush, MD, MBA